@article{c3606b53d7894f489b366eac2bcf0b1f,
title = "Efficacy and safety of daratumumab combined with all-trans retinoic acid in relapsed/refractory multiple myeloma",
keywords = "CD38 EXPRESSION, OPEN-LABEL, INTRAVENOUS DARATUMUMAB, UP-REGULATION, CELLS, DEXAMETHASONE, LENALIDOMIDE, MONOTHERAPY, BORTEZOMIB, EXPANSION",
author = "K.A. Frerichs and M.C. Minnema and M.D. Levin and A. Broijl and G.M.J. Bos and M.J. Kersten and T. Mutis and C.P.M. Verkleij and I.S. Nijhof and P.W.C. Maas-Bosman and S.K. Klein and S. Zweegman and P. Sonneveld and {van de Donk}, N.W.C.J.",
year = "2021",
month = dec,
day = "14",
doi = "10.1182/bloodadvances.2021005220",
language = "English",
volume = "5",
pages = "5128--5139",
journal = "Blood advances",
issn = "2473-9529",
publisher = "The American Society of Hematology",
number = "23",
}